Combination PancVAX neo-epitope vaccine with anti-CTLA-4 and anti-PD-1 antibodies enhances infiltration of cytotoxic T cells and mitigates T cell exhaustion in a murine model of pancreatic ductal adenocarcinoma

被引：0
|
作者：
Mitchell, Jacob T.
Huff, Amanda
Davis-Marcisak, Emily
Chen, Fangluo
Armstrong, Todd D.
Kagohara, Luciane T.
Leatherman, James
Wang, Rulin
Yegnasubramanian, Srinivasan
Jaffee, Elizabeth M.
Fertig, Elana J.
Zaidi, Neeha
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5076
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5076
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Enrichment of IL-17-producing CD4+ T Cells in Synovial Fluid from Patients with Arthritis After anti-CTLA-4 and anti-PD-1 Combination Therapy
    Kim, Sang
    Tayar, Jean
    Suarez-Almazor, Maria E.
    Lu, Huifang
    Zhao, Yang-Zhi
    Liu, Zhongshan
    Rodriguez, Emma
    Neelapu, Sattva
    Wang, Jennifer
    Shah, Amishi
    Tannir, Nizar
    Gibbons, Don
    Garcia-Manero, Guillermo
    Tawbi, Hussein
    Hwu, Patrick
    Futreal, Andrew
    Diab, Adi
    Nurieva, Roza
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [22] Anti-CTLA-4 synergizes with dendritic cell-targeted vaccine to promote IL-3-dependent CD4+ effector T cell infiltration into murine pancreatic tumors
    Zaidi, Neeha
    Quezada, Sergio A.
    Kuroiwa, Janelle M. Y.
    Zhang, Li
    Jaffee, Elizabeth M.
    Steinman, Ralph M.
    Wang, Bei
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1445 (01) : 62 - 73
  • [23] Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking
    Taggart, David
    Andreou, Tereza
    Scott, Karen J.
    Williams, Jennifer
    Rippaus, Nora
    Brownlie, Rebecca J.
    Ilett, Elizabeth J.
    Salmond, Robert J.
    Melcher, Alan
    Lorger, Mihaela
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (07) : E1540 - E1549
  • [24] Targeting the Stroma to Enhance T-Cell Infiltration and Anti-tumor Response to Anti-PD1 Antibody in Pancreatic Ductal Adenocarcinoma
    Osipov, A.
    Zheng, L.
    PANCREAS, 2020, 49 (10) : 1422 - 1423
  • [25] Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model
    Park, J. S.
    Ham, W. S.
    Lee, M. E.
    Jang, W. S.
    Oh, K.
    Lee, N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S557 - S557
  • [26] Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines
    Yuan, Zhaohu
    Yang, Huikuan
    Wei, Yaming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (01): : 123 - 132
  • [27] Synergistic efficacy of anti-PD-L1/IL-15 fusion protein in combination with anti-CTLA-4 antibody in a murine orthotopic 4T1 breast carcinoma model
    Martomo, Stella
    Lu, Dan
    Patel, Jeegar
    Polonskaya, Zhanna
    Luna, Xenia
    McCracken, Kevin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [28] TARGETING THE STROMA TO ENHANCE EFFECTOR MEMORY T CELL INFILTRATION AND ANTI-TUMOR RESPONSE TO ANTI-PD1 ANTIBODY IN PANCREATIC DUCTAL ADENOCARCINOMA
    Osipov, A.
    Zheng, L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A59 - A60
  • [29] Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
    Amaro, Adriana
    Reggiani, Francesco
    Fenoglio, Daniela
    Gangemi, Rosaria
    Tosi, Anna
    Parodi, Alessia
    Banelli, Barbara
    Rigo, Valentina
    Mastracci, Luca
    Grillo, Federica
    Cereghetti, Alessandra
    Tastanova, Aizhan
    Ghosh, Adhideb
    Sallustio, Fabio
    Emionite, Laura
    Daga, Antonio
    Altosole, Tiziana
    Filaci, Gilberto
    Rosato, Antonio
    Levesque, Mitchell
    Maio, Michele
    Pfeffer, Ulrich
    Croce, Michela
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [30] Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
    Adriana Amaro
    Francesco Reggiani
    Daniela Fenoglio
    Rosaria Gangemi
    Anna Tosi
    Alessia Parodi
    Barbara Banelli
    Valentina Rigo
    Luca Mastracci
    Federica Grillo
    Alessandra Cereghetti
    Aizhan Tastanova
    Adhideb Ghosh
    Fabio Sallustio
    Laura Emionite
    Antonio Daga
    Tiziana Altosole
    Gilberto Filaci
    Antonio Rosato
    Mitchell Levesque
    Michele Maio
    Ulrich Pfeffer
    Michela Croce
    Journal of Experimental & Clinical Cancer Research, 42
12345